IRIS
GIACOBBE, DANIELE ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.325
Totale 13.325
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.325
Totale 13.325
Salva come PNG Salva come JPEG
Città #
Genova 6.926
Vado Ligure 2.186
Genoa 2.116
Rapallo 2.019
Bordighera 78
Totale 13.325
Salva come PNG Salva come JPEG
Nome #
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy 246
Emergence of a KPC-3-Producing Escherichia coli ST69 as a Cause of Bloodstream Infections in Italy 186
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 170
Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil 168
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. 160
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: should we get to the PK/PD root of the paradox? 146
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: Findings from a multicenter prospective observational study 142
Epidemiology, management, and outcome of carbapenem-resistant Klebsiella pneumoniae bloodstream infections in hospitals within the same endemic metropolitan area 142
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 141
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery 139
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study 137
Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' response 132
Increasing incidence of Clostridium difficile infections: results from a 5-year retrospective study in a large teaching hospital in the Italian region with the oldest population 128
Use of colistin in adult patients: a cross-sectional study 128
Commentary: Human Immunodeficiency Virus and Allergic Bronchopulmonary Aspergillosis 126
Will new antimicrobials overcome resistance among Gram-negatives? 125
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 125
Early carbapenem-resistant Klebsiella pneumoniae bacteraemia: should we expand the screening? 124
Regional point prevalence study of healthcare-associated infections and antimicrobial use in acute care hospitals in Liguria, Italy 124
Management of KPC-producing Klebsiella pneumoniae infections 123
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 122
Incidence and outcome of invasive candidiasis in intensive care units (icus) in europe: Results of the eucandicu project 122
Post-operative abdominal infections: epidemiology, operational definitions, and outcomes 121
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 119
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 118
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 118
Treatment of Infections Due to MDR Gram-Negative Bacteria 117
The Beta-d-glucan Test: Time to Re-Visit Its Utility in IFI Diagnosis 115
Trends in the annual incidence of carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A 8-year retrospective study in a large teaching hospital in northern Italy 114
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 113
Respiratory Fungal Diseases in Adult Patients With Cystic Fibrosis 106
Risk factors andmortality of healthcare-associated and community-acquired Staphylococcus aureusbacteraemia 102
null 102
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from multicenter case-control-control-study. 102
Aortic cross-clamp time and cardiopulmonary bypass time: prognostic implications in patients operated on for infective endocarditis 102
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients with Infections Caused by Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae 102
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 102
Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor 101
Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery 100
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 99
Ceftolozane/tazobactam: place in therapy 99
Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment 98
Coagulative Disorders in Critically Ill COVID-19 Patients with Acute Distress Respiratory Syndrome: A Critical Review 95
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 92
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 91
Tick-borne encephalitis in Europe: a brief update on epidemiology, diagnosis, prevention, and treatment 91
The role of fosfomycin for multidrug-resistant gram-negative infections 91
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals 90
New insights into infections due to multidrug resistant gram negative bacteria: The interplay between lab and clinic 90
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 90
Bloodstream infections in critically ill patients with COVID-19 90
Pregnancy outcomes following exposure to efavirenz-based antiretroviral therapy in the Republic of Congo 89
Bloodstream infections in internal medicine 89
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 89
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 88
Impact of negative blood cultures on outcome after surgery for acute infective endocarditis 88
Epidemiology and outcome of Klebsiellapneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-KP) infections in cardiac surgery patients: a brief narrative review 88
Ceftobiprole: drug evaluation and place in therapy 88
First report of chronic pulmonary infection by KPC-3-producing and colistin-resistant Klebsiella pneumoniae sequence type 258 (ST258) in an adult patient with cystic fibrosis 87
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after cardiac surgery 82
Factors associated with lack of viral suppression at delivery 82
Efficacy and Safety of Meropenem–Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc Analysis 81
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 81
EReply. Diagnostic intricacies and fortuitous treatment approaches for carbapenem-resistant Klebsiella pneumoniae 80
Pharmacokinetics of high-dose extended-infusion meropenem during pulmonary exacerbation in adult cystic fibrosis patients: a case series 80
Pitfalls of defining combination therapy for carbapenem-resistant Enterobacteriaceae in observational studies 79
History of schistosomiasis (bilharziasis) in humans: from Egyptian medical papyri to molecular biology on mummies 79
Colistin versus colistin plus meropenem for severe infections 78
Valutazione dei fattori di rischio per lo sviluppo di candidemia dopo interventi di cardiochirurgia maggiore 78
A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemic 78
A look at clinical trial design for new antimicrobials for the adult population 75
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 75
Culture-negative infective endocarditis (CNIE): impact on postoperative mortality 75
Early Detection of Sepsis With Machine Learning Techniques: A Brief Clinical Perspective 74
Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project 73
Reduced Incidence of Carbapenem-Resistant Klebsiella pneumoniae Infections in Cardiac Surgery Patients after Implementation of an Antimicrobial Stewardship Project 73
The diagnostic conundrum of bacterial infections in cirrhotic patients 72
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors 72
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia 72
Recent advances in the pharmacological management of infections due to multidrug-resistant Gram-negative bacteria 71
The safety of treatment options for acute bacterial skin and skin structure infections 71
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 71
Diagnosis and Treatment of Candidemia in the Intensive Care Unit 70
Chest physiotherapy: An important adjuvant in critically ill mechanically ventilated patients with COVID-19 70
Role of fecal microbiota transplantation in inflammatory bowel disease 69
Distinct phenotypes require distinct respiratory management strategies in severe COVID-19 69
Comment on: Mortality due to blaKPC klebsiella pneumoniae bacteraemia 68
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP) 68
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 68
Risk factors for candidemia after open-heart surgery: results from a multicenter case-control study 64
Isolation of Candida auris from invasive and noninvasive samples of a patient suffering from vascular disease, Italy, July 2019 61
The COVID-19 insidious trick: Subjective perception of numbers 61
Use of ceftaroline in hospitalized patients with and without covid-19: A descriptive cross-sectional study 61
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 59
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 59
Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia 58
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 58
Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy 58
Insights on common vaccinations in HIV-infection: efficacy and safety 57
Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients 57
Totale 9.719
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.901
article - articoli 62.229
book - libri 0
conference - conferenze 782
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 682
Totale 127.594
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.977 0 0 0 0 0 345 364 251 295 404 234 84
2020/20211.704 74 150 178 101 87 99 113 189 160 220 165 168
2021/20221.858 72 52 93 182 87 134 68 357 223 194 108 288
2022/20232.479 222 207 31 235 296 325 85 161 403 145 304 65
2023/20241.695 81 187 45 217 150 252 143 112 84 77 128 219
2024/20252.415 154 360 159 395 793 554 0 0 0 0 0 0
Totale 13.931